Freshfields Helps Novartis Buy German Pharma In €2.7B Deal
By Najiyya Budaly · February 6, 2024, 1:51 PM GMT
Swiss pharmaceutical giant Novartis AG has agreed to buy MorphoSys AG in a deal that values the German biopharmaceutical group at €2.7 billion ($2.9 billion) as it seeks to develop its...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login